- Home
- MIRM
as of 12-12-2025 10:55am EST
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | FOSTER CITY |
| Market Cap: | 3.7B | IPO Year: | 2019 |
| Target Price: | $87.55 | AVG Volume (30 days): | 616.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $36.88 - $78.55 | Next Earning Date: | 11-04-2025 |
| Revenue: | $471,794,000 | Revenue Growth: | 53.66% |
| Revenue Growth (this year): | 53.78% | Revenue Growth (next year): | 19.91% |
AI-Powered MIRM Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Mirum Pharmaceuticals Inc. (MIRM)
Director
Avg Cost/Share
$74.00
Shares
50,000
Total Value
$3,700,000.00
Owned After
0
SEC Form 4
Director
Avg Cost/Share
$70.00
Shares
50,000
Total Value
$3,500,000.00
Owned After
0
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| GREY MICHAEL G | MIRM | Director | Dec 1, 2025 | Sell | $74.00 | 50,000 | $3,700,000.00 | 0 | |
| GREY MICHAEL G | MIRM | Director | Nov 21, 2025 | Sell | $70.00 | 50,000 | $3,500,000.00 | 0 |
Compare MIRM vs Leading Stocks
See how MIRM stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MIRM Mirum Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.